CRISPR CAS9 2015: An interview with Dr Ping Zhang of Oxford University


Chanice Henry
02/07/2016

Pharma IQ speaks to Dr Ping Zhang of Oxford University about the market behind gene editing technique CRISPR CAS9.

Have Your Say

Rate this feature and give us your feedback in the comments section below

TO READ THE FULL STORY